Papaverine and oxytocin for safer labor induction
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests whether adding papaverine, a smooth-muscle relaxant, to the standard labor-inducing drug oxytocin can make labor quicker and safer. It is for first-time mothers carrying a single baby head-down who need to start labor with oxytocin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You are pregnant with one baby (a singleton pregnancy) between 37 and 42 weeks.
- Your baby is positioned head-down (cephalic presentation).
- Your doctor has decided you need oxytocin to start labor.
- This is your first baby (nulliparity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests the safety of a medicine used to help start labor (“induction”). It may help by aiming for a safer, smoother induction process for people who are ready to deliver and meet specific pregnancy and health criteria.
This study tests whether a medicine called papaverine can shorten the pushing phase of labor in women whose labor is started with a balloon catheter. If you are planning a vaginal delivery and meet the other criteria, you may be able to join.
This study tests whether an IV medication called papaverine can help induce labor in pregnant people at term (37+ weeks) whose water has broken but labor hasn't started yet. The goal is to see if this medication makes labor start naturally and reduces the need for cesarean delivery.
This trial tests whether papaverine, a medication that relaxes muscles, can reduce tearing and injury to the perineum (the area between the vagina and rectum) during vaginal birth. If it works, it could help first-time mothers heal better after delivery.
This trial tests oxytocin, a drug used to start or strengthen labor, in women who have given birth before and are being induced with a full-term, single baby. It aims to find the best way to use oxytocin safely and effectively.
This trial tests whether giving a drug called propranolol (a beta-blocker) can shorten the time between starting labor induction and delivery for women who are getting oxytocin. If you are having a single baby in head-down position at full term, this study might be relevant to you.
Hear when a new Labor Onset and Length Abnormalities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.